NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Cash Flow Reinvestment Rate
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $109.43K (capex $109.43K ) from operating cash flow of $29.19 Million. See NAMS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NewAmsterdam Pharma Company N.V. Ordinary Shares Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of NewAmsterdam Pharma Company N.V. Ordinar.
Annual Cash Flow Reinvestment Rate for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Year-by-year capital reinvestment analysis for NewAmsterdam Pharma Company N.V. Ordinary Shares. See NewAmsterdam Pharma Company N.V. Ordinar (NAMS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.09x | $936.00K | $10.66 Million | $221.00K | — |